Venture Capital

Electric Power Engineers: Strategic Growth Investment Raised From Berkshire Partners

By Amit Chowdhry ● Jan 9, 2025

Electric Power Engineers (EPE), a leading energy and power systems engineering and consulting firm, announced it received a significant strategic growth investment from Boston-based private equity firm Berkshire Partners.

CourseKey Raises Strategic Growth Investment From PSG

By Amit Chowdhry ● Jan 9, 2025

PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled service companies to help navigate and capitalize on transformational growth, announced a strategic growth investment in CourseKey - a student success platform purpose-built for vocational education. CourseKey joins PSG's investments in Verity IQ and Campus Ivy, which creates a unified and end-to-end technology suite for career-focused and vocational education providers.

Deciphex: $32.3 Million (Series C) Raised For Addressing The Global Pathology Crisis

By Amit Chowdhry ● Jan 9, 2025

Deciphex, an AI-based digital pathology leader, announced it has closed its Series C funding at $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories, IRRUS Investments, HBAN Medtech Syndicate, and Nextsteps Capital, this funding will advance Deciphex's mission to democratize access to high-quality pathology through a technology-enabled global network of pathologists.

FIRE1: $120 Million Funding Raised For Transforming Heart Failure Care

By Amit Chowdhry ● Jan 9, 2025

FIRE1 - a leading connected medical device solutions company - announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The funding round was led by Polaris Partners and Elevage Medical Technologies and joined by new investors Sands Capital and Longitude Capital, and existing investors Andera Partners, Gilde Healthcare, Gimv, the Ireland Strategic Investment Fund, Lightstone Ventures, Medtronic, NEA (New Enterprise Associates), Novo Holdings, and Seventure Partners.

Jones: Insurance Verification Company Raises $15 Million (Series B)

By Amit Chowdhry ● Jan 9, 2025

Jones, the vertical software company leading AI innovation in insurance verification, announced the closing of its $15 million Series B funding round led by NewSpring Growth. The funding round also saw continued participation from major existing investors, including Hetz Ventures, Camber Creek, Khosla Ventures, JLL Spark, DivcoWest Ventures, Rudin Ventures, and Ground Up Ventures.

XyloCor Therapeutics: $67.5 Million (Series B) Raised For Advancing Clinical Development Of Gene Therapy In Cardiovascular Disease

By Amit Chowdhry ● Jan 8, 2025

XyloCor Therapeutics - a clinical-stage biopharmaceutical company developing novel gene therapies for cardiovascular disease - announced the completion of a $67.5 million Series B financing. And the new investment will support a randomized, double-blind Phase 2b clinical trial (EXACT-2) of XC001 (encoberminogene rezmadenovec), in refractory angina, using a new non-surgical method of endocardial administration via a novel injection catheter.

Waterpoint Lane: Fund I Closed To Advance Food Innovation

By Amit Chowdhry ● Jan 8, 2025

Waterpoint Lane announced the closing of its inaugural fund, Waterpoint Lane Sustainability Fund I. Fund I attracted strong support from a distinguished global investor base, including premier family offices and high-net-worth individuals, all united by a commitment to advancing impact and innovation within the global food system.

Whatnot: Live Shopping Company Raises $265 Million (Series E) At $4.97 Billion Valuation

By Amit Chowdhry ● Jan 8, 2025

Whatnot, the largest marketplace focused on live shopping in the U.S., UK, and Europe, announced $265 million in Series E funding, co-led by Greycroft, DST Global, and Avra. Also joining are Greycroft and Avra, who are new investors. It also included Lightspeed Venture Partners and Durable Capital Partners, who participated in the round alongside returning investors Andreessen Horowitz (a16z), CapitalG, BOND, and Y Combinator. This investment brings Whatnot’s valuation to $4.97 billion. Since its founding, Whatnot has raised approximately $746 million.

Flavor Insights: Growth Financing Raised From BizCap

By Amit Chowdhry ● Jan 8, 2025

BizCap (a national commercial finance and advisory firm) announced it has delivered a customized financing solution for its client Flavor Insights. Flavor Insights is a flavor development business founded in 2016 and the company partners with top food and beverage brands to provide ingredients for existing brands and collaborates with R&D teams to develop and deliver new products.

MDaudit: Strategic Investment Raised From Bregal Sagemount And Primus Capital

By Amit Chowdhry ● Jan 8, 2025

MDaudit - a provider of billing, coding compliance, and revenue integrity software for health systems, hospitals, and provider groups - announced a strategic growth investment from Bregal Sagemount and Primus Capital. The terms of the deal were undisclosed.

Alesta Therapeutics: €65 Million (Series A) Raised To Develop Small Molecule Therapies For Rare Diseases

By Amit Chowdhry ● Jan 8, 2025

Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, announced the closing of an oversubscribed €65 million Series A funding round. This funding round was co-led by Frazier Life Sciences and Droia Ventures, with participation from Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital, and SSI Strategy.

Aviceda Therapeutics: $207.5 Million (Series C) Raised To Develop Next-Generation Immunomodulators

By Amit Chowdhry ● Jan 8, 2025

Aviceda Therapeutics, a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity Ligands of Siglecs (HALOS) nanotechnology platform to alleviate chronic, non-resolving inflammation, announced the closing of a $207.5 million Series C funding.

Cold Bore Capital Management: Interview With Co-Founder & Partner Matt Schachman About The Veteran-Led PE Firm

By Amit Chowdhry ● Jan 8, 2025

Cold Bore Capital is a veteran-led private equity firm based in Chicago that uniquely specializes in small-cap buyouts, targeting businesses within the lower-middle market with EBITDAs ranging from $500K to $5 million. The firm’s Operations Group is fully staffed by veterans from elite military units, including Navy SEALs, Green Berets, Army Rangers, Air Force PJs/CCTs, Marine Raiders/Force Reconnaissance, Navy SWCC, Strike/Fighter or SOF Aviators, and Navy EOD. Pulse 2.0 interviewed Cold Bore Capital co-founder and partner Matt Schachman to learn more about the firm.